Insufficient scRNA-seq data for expression of ULBP2 at single-cell level.
Insufficient scRNA-seq data for expression of ULBP2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 205.54 | 578 / 578 | 70% | 17.04 | 811 / 1155 |
thymus | 93% | 51.80 | 607 / 653 | 75% | 9.62 | 456 / 605 |
adrenal gland | 86% | 41.53 | 223 / 258 | 70% | 9.78 | 161 / 230 |
esophagus | 55% | 111.92 | 801 / 1445 | 88% | 24.29 | 161 / 183 |
kidney | 93% | 63.20 | 83 / 89 | 39% | 2.50 | 355 / 901 |
brain | 77% | 70.30 | 2047 / 2642 | 35% | 2.57 | 247 / 705 |
uterus | 28% | 9.08 | 47 / 170 | 82% | 27.40 | 376 / 459 |
pancreas | 35% | 9.94 | 114 / 328 | 72% | 8.38 | 129 / 178 |
bladder | 33% | 24.62 | 7 / 21 | 73% | 15.18 | 370 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.42 | 1 / 1 |
breast | 72% | 41.33 | 330 / 459 | 28% | 2.86 | 311 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 96% | 34.42 | 43 / 45 |
skin | 59% | 108.87 | 1071 / 1809 | 35% | 3.16 | 166 / 472 |
heart | 94% | 59.56 | 806 / 861 | 0% | 0 | 0 / 0 |
adipose | 79% | 53.42 | 952 / 1204 | 0% | 0 | 0 / 0 |
intestine | 24% | 7.63 | 236 / 966 | 50% | 6.43 | 261 / 527 |
stomach | 28% | 8.75 | 101 / 359 | 37% | 3.91 | 107 / 286 |
blood vessel | 52% | 24.58 | 695 / 1335 | 0% | 0 | 0 / 0 |
prostate | 27% | 7.66 | 66 / 245 | 15% | 1.32 | 76 / 502 |
liver | 22% | 9.57 | 49 / 226 | 14% | 1.40 | 55 / 406 |
peripheral blood | 23% | 8.65 | 212 / 929 | 0% | 0 | 0 / 0 |
muscle | 21% | 5.65 | 171 / 803 | 0% | 0 | 0 / 0 |
ovary | 4% | 1.51 | 8 / 180 | 14% | 0.91 | 60 / 430 |
spleen | 17% | 5.71 | 41 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 5% | 0.20 | 4 / 80 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.11 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006955 | Biological process | immune response |
GO_0030101 | Biological process | natural killer cell activation |
GO_0002476 | Biological process | antigen processing and presentation of endogenous peptide antigen via MHC class Ib |
GO_0002486 | Biological process | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent |
GO_0001916 | Biological process | positive regulation of T cell mediated cytotoxicity |
GO_0042267 | Biological process | natural killer cell mediated cytotoxicity |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005615 | Cellular component | extracellular space |
GO_0009986 | Cellular component | cell surface |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0046703 | Molecular function | natural killer cell lectin-like receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ULBP2 |
Protein name | UL16-binding protein 2 (ALCAN-alpha) (NKG2D ligand 2) (N2DL-2) (NKG2DL2) (Retinoic acid early transcript 1H) |
Synonyms | RAET1H UNQ463/PRO791 N2DL2 |
Description | FUNCTION: Binds and activates the KLRK1/NKG2D receptor, mediating natural killer cell cytotoxicity. . |
Accessions | Q9BZM5 ENST00000367351.4 |